{"id":3410,"date":"2021-07-16T19:48:11","date_gmt":"2021-07-16T19:48:11","guid":{"rendered":"http:\/\/deepfda.com\/?page_id=3410"},"modified":"2024-10-19T20:06:36","modified_gmt":"2024-10-19T20:06:36","slug":"%e7%94%9f%e7%89%a9%e5%ae%89%e5%85%a8%e7%ba%a7%e5%88%ab-bsl-2p2%e6%88%96-bsl-3-p3%e5%ae%9e%e9%aa%8c%e5%ae%a4%e6%9c%8d%e5%8a%a1","status":"publish","type":"page","link":"https:\/\/deepfda.com\/us\/%e7%94%9f%e7%89%a9%e5%ae%89%e5%85%a8%e7%ba%a7%e5%88%ab-bsl-2p2%e6%88%96-bsl-3-p3%e5%ae%9e%e9%aa%8c%e5%ae%a4%e6%9c%8d%e5%8a%a1\/","title":{"rendered":"Biosafety Level BSL-2 (P2) or BSL-3 (P3) Laboratory Services"},"content":{"rendered":"

<\/div><\/div><\/div>
<\/div>

Biodefense<\/span>Biosafety Level BSL-2 (P2) or BSL-3 (P3) Laboratory Services<\/span><\/span><\/h3>
Provide emergency priority access to candidate drug services in a biosafety level laboratory. <\/div><\/header>
<\/div>
<\/p>\n

Decouvor collaborates with multiple globally licensed biological laboratories to develop candidate therapeutics for medical responses to bioterrorism, including those targeting Bacillus anthracis and Yersinia pestis. We offer biosafety level BSL-2 (P2) and BSL-3 (P3) laboratory services.<\/p>\n

\n<\/div>

<\/div><\/div><\/div><\/div>
<\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/section>
<\/div><\/div><\/div>
<\/div>

Biodefense<\/span>Biosafety Laboratory Animal Model Research<\/span><\/span><\/h3>
Provision of Animal Models for Experimental Research: Syrian Hamster, hACE2 Mouse, Crab-Eating Macaque, Rhesus Macaque, and African Green Monkey<\/div><\/header>
<\/div>
<\/p>\n

In collaboration with multiple globally certified laboratories with biosafety licenses, we conduct preclinical studies in BSL-2 (P2) or BSL-3 (P3) laboratories. Our services include developing experimental protocols, optimizing candidate drug formulations, adhering to regulatory requirements, actively engaging with regulatory authorities, and providing biosafety data that meets regulatory standards.<\/p>\n

\n<\/div>

<\/div><\/div><\/div><\/div>
<\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/section>
<\/div><\/div><\/div>
<\/div>

Biodefense<\/span>Biosafety Laboratory In Vitro Assays<\/span><\/span><\/h3>
Analysis of Drug Concentration in Tissues and Organs<\/div><\/header>
<\/div>
<\/p>\n

In collaboration with multiple globally certified laboratories with biosafety licenses, we conduct in vitro studies in BSL-2 (P2) or BSL-3 (P3) laboratories. Our assays include ELISA, biomarker cytokine expression analysis, immunogenicity testing, qPCR and RT-qPCR assays, immunological assessments, and inhalation toxicology testing.<\/p>\n

\n<\/div>

<\/div><\/div><\/div><\/div>
<\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/section>
<\/div><\/div>
<\/div><\/div><\/div>
<\/div>

Biodefense<\/span>Aerosol Challenge Study<\/span><\/span><\/h3>
Aerosol Challenge Testing of Pathogens and Specific Toxins under Biosafety Level BSL-3 Conditions<\/div><\/header>
<\/div>
<\/p>\n

Evaluation services for treatments or vaccine research targeting aerosol-transmitted diseases, including highly pathogenic influenza, SARS-CoV-2, and Middle East Respiratory Syndrome (MERS). We provide experimental models involving non-human primates and rodents.<\/p>\n

\n<\/div>

<\/div><\/div><\/div><\/div>
<\/div><\/div><\/div><\/div><\/div>
<\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/section><\/p>","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":2792,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-3410","page","type-page","status-publish","has-post-thumbnail","hentry"],"_links":{"self":[{"href":"https:\/\/deepfda.com\/us\/wp-json\/wp\/v2\/pages\/3410","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/deepfda.com\/us\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/deepfda.com\/us\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/deepfda.com\/us\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/deepfda.com\/us\/wp-json\/wp\/v2\/comments?post=3410"}],"version-history":[{"count":21,"href":"https:\/\/deepfda.com\/us\/wp-json\/wp\/v2\/pages\/3410\/revisions"}],"predecessor-version":[{"id":3917,"href":"https:\/\/deepfda.com\/us\/wp-json\/wp\/v2\/pages\/3410\/revisions\/3917"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/deepfda.com\/us\/wp-json\/wp\/v2\/media\/2792"}],"wp:attachment":[{"href":"https:\/\/deepfda.com\/us\/wp-json\/wp\/v2\/media?parent=3410"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}